Since the rollout of COVID-19 vaccines in 2021, embalmers worldwide have reported an alarming phenomenon: the presence of unusual white, fibrous clots in deceased individuals. These observations, detailed in the 2024 Worldwide Embalmer Blood Clot Survey conducted by retired US Air Force Major Thomas F. Haviland, raise serious questions about post-vaccine health effects. This essay delves into the survey's findings, the characteristics of these clots, their potential link to COVID-19 vaccines, and the broader implications for medical science and public health.

The 2024 Worldwide Embalmer Blood Clot Survey

Conducted from November 11 to December 14, 2024, across the United States, Canada, the United Kingdom, and Australia, Haviland's survey collected responses from 301 embalmers. The results are striking:

Prevalence of Clots: 83% of embalmers reported observing white, fibrous clots in an average of 27.5% of corpses in 2024, up from 73% in 2023 and 67% in 2022. These clots were rarely, if ever, seen before 2021.

Micro-Clotting: 70% of respondents noted micro-clotting, described as "coffee grounds" or "dirty blood," in 22% of cases.

Vaccination Correlation: Of 1,425 respondents reporting clotting issues, 91% had received at least one COVID-19 vaccine dose. Only 79 cases of these clots were reported in 2020 (pre-vaccine), compared to over 500 annually from 2021 to 2024.

Infant Mortality: 39% of embalmers observed a 14% average increase in infant deaths compared to pre-2020 levels.

Geographic Consistency: Reports came from multiple regions, with embalmers in Virginia, New York, and Idaho noting similar patterns. For example, a Virginia embalmer stated, "I'm finding a lot of the white rubbery clots… it's become the new normal," while a New York embalmer with 12 years of experience remarked, "I have never seen anything like this."

A parallel survey by the Tennessee Funeral Directors Association (TFDA), also conducted by Haviland in 2025, corroborated these findings. At the TFDA convention in Franklin, Tennessee, 28 embalmers reported that 64% saw white fibrous clots in 17% of corpses, with 70% noting micro-clotting.

Characteristics of the Clots

The clots described are distinct from typical thrombi. According to biochemical analyses cited in the survey, they exhibit the following traits:

Composition: The clots are amyloidogenic fibrin aggregates, abnormal, protease-resistant protein structures. They show altered fibrinogen ratios and elevated phosphorus content, suggesting pathological remodelling of fibrin.

Appearance: Described as white, rubbery, and fibrous, these clots differ from the dark, gelatinous clots associated with traditional thrombosis. Embalmers report needing forceps to remove them, as they clog drainage tubes.

Prion Activity: The clots tested positive for prion seeding via RT-QuIC, a method used to detect misfolded proteins associated with diseases like Creutzfeldt-Jakob disease. This raises concerns about potential infectious or neurodegenerative risks, though no peer-reviewed studies confirm this link, yet.

Prevalence in Vaccinated Individuals: The clots are predominantly observed in individuals who received COVID-19 vaccines, particularly those with multiple doses (e.g., 5–6 doses reported in some Idaho cases).

Potential Link to COVID-19 Vaccines

The temporal correlation between the vaccine rollout and the emergence of these clots is a focal point of the survey. Haviland notes that the clots were virtually absent in 2020, before vaccines were widely administered, but became prevalent from 2021 onward. Embalmers report a higher incidence in younger individuals (e.g., 50–60-year-olds) dying from massive heart attacks, with clots consistently present. A New York embalmer remarked, "Every one of them has had clots as discussed in this survey."

However, establishing causation is complex. The survey suggests a link to the spike protein produced by mRNA vaccines, which may trigger abnormal fibrin formation. Dr. Kevin McCairn's analysis, cited in the survey, posits that spike protein interactions with fibrin could lead to amyloid-like aggregates. Yet, no definitive peer-reviewed studies confirm this mechanism, yet, because there is no funding for this. Other factors, such as long COVID, changes in embalming practices, or underlying health conditions exacerbated by the pandemic, could contribute, but are not addressed in the survey.

Limitations of the Survey

While the findings are compelling, the survey has notable limitations:

Sample Size and Bias: With only 301 respondents, the survey represents a small fraction of global embalmers. Self-selection bias may skew results, as embalmers noticing unusual clots may be more likely to participate.

Lack of Peer Review: The biochemical analyses (e.g., prion seeding, fibrinogen ratios) are not published in peer-reviewed journals, limiting their credibility, for a dogmatic mainstream. Claims about amyloidogenic clots rely on preliminary data from researchers like McCairn, which require further validation.

No Control Group: The survey lacks a control group of unvaccinated individuals or pre-2020 cadavers to establish baseline clotting rates.

Anecdotal Reports: Embalmer testimonies, while vivid, are subjective and lack standardised criteria for clot identification. Still clots either exist or do not.

Institutional Silence: Haviland submitted findings to the FDA, CDC, and NIH, but received no response. While this could reflect methodological concerns or institutional caution, it is more likely a cover-up for their masters, Big Pharma.

The survey's findings, if substantiated, have profound implications for public health:

Vaccine Safety: A confirmed link between COVID-19 vaccines and these clots would necessitate urgent re-evaluation of vaccine safety protocols, particularly for booster doses. The rise in infant mortality and younger deaths reported by embalmers adds to the urgency.

Medical Research: The amyloid-like nature of the clots and their prion-like properties, warrant investigation into potential long-term risks, such as neurodegenerative diseases or vascular complications.

Public Trust: The lack of response from health authorities produces distrust, particularly among those already sceptical of vaccines, and rightly so. Transparent investigation could mitigate misinformation and conspiracy narratives, but the health authorities are too much under big Pharma control for this.

Embalming Practices: The clots' impact on embalming (e.g., clogging drainage tubes) may require changes in techniques, affecting funeral industry standards.

The 2024 Worldwide Embalmer Blood Clot Survey highlights a disturbing trend that cannot be ignored. The consistent reports of white, fibrous clots across multiple regions, coupled with their absence before 2021, suggest a phenomenon worthy of scientific scrutiny. While the survey's limitations prevent definitive conclusions, its findings demand immediate action:

Independent Studies: Peer-reviewed research is needed to confirm the clots' composition, prevalence, and link to vaccines. Autopsy studies comparing vaccinated and unvaccinated cadavers could clarify causality.

Health Authority Engagement: The FDA, CDC, and WHO should investigate these reports, addressing embalmer observations and biochemical claims transparently; but they won't.

Public Communication: Clear, evidence-based communication is essential to address public concerns and keep the momentum up against the COVID vaxxes.

The unusual clots reported by embalmers represent a critical signal in post-vaccine health surveillance. While the survey alone cannot prove causation, it underscores the need for rigorous, transparent science to protect public health. Ignoring these findings, which is most likely in a corrupt medical establishment, risks further eroding confidence in medical institutions, which at this late stage of the game, seems inevitable.

https://libertysentinel.org/vaccines-depopulation-and-nanotechnology-part-3/